BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 7776173)

  • 1. A review of the evidence supporting melatonin's role as an antioxidant.
    Reiter RJ; Melchiorri D; Sewerynek E; Poeggeler B; Barlow-Walden L; Chuang J; Ortiz GG; Acuña-Castroviejo D
    J Pineal Res; 1995 Jan; 18(1):1-11. PubMed ID: 7776173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
    Reiter RJ
    Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin in relation to cellular antioxidative defense mechanisms.
    Reiter RJ; Carneiro RC; Oh CS
    Horm Metab Res; 1997 Aug; 29(8):363-72. PubMed ID: 9288572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygen radical detoxification processes during aging: the functional importance of melatonin.
    Reiter RJ
    Aging (Milano); 1995 Oct; 7(5):340-51. PubMed ID: 8719600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of the pineal hormone melatonin with oxygen-centered free radicals: a brief review.
    Reiter RJ
    Braz J Med Biol Res; 1993 Nov; 26(11):1141-55. PubMed ID: 8136717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological actions of melatonin in oxygen radical pathophysiology.
    Reiter R; Tang L; Garcia JJ; Muñoz-Hoyos A
    Life Sci; 1997; 60(25):2255-71. PubMed ID: 9194681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin.
    Reiter RJ; Guerrero JM; Garcia JJ; Acuña-Castroviejo D
    Ann N Y Acad Sci; 1998 Nov; 854():410-24. PubMed ID: 9928448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of oxygen toxicity by melatonin.
    Reiter RJ; Tan DX; Qi WB
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence.
    Reiter RJ; Tan DX; Manchester LC; Qi W
    Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the neurohormone melatonin as a buffer against macromolecular oxidative damage.
    Reiter RJ
    Neurochem Int; 1995 Dec; 27(6):453-60. PubMed ID: 8574173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger.
    Tan DX; Reiter RJ; Manchester LC; Yan MT; El-Sawi M; Sainz RM; Mayo JC; Kohen R; Allegra M; Hardeland R
    Curr Top Med Chem; 2002 Feb; 2(2):181-97. PubMed ID: 11899100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of melatonin in antioxidative defense system: reactions and products.
    Tan DX; Manchester LC; Reiter RJ; Qi WB; Karbownik M; Calvo JR
    Biol Signals Recept; 2000; 9(3-4):137-59. PubMed ID: 10899700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin's unique radical scavenging properties - roles of its functional substituents as revealed by a comparison with its structural analogs.
    Poeggeler B; Thuermann S; Dose A; Schoenke M; Burkhardt S; Hardeland R
    J Pineal Res; 2002 Aug; 33(1):20-30. PubMed ID: 12121482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants.
    Reiter RJ; Tan DX; Allegra M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():3-8. PubMed ID: 12019343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Free oxygen radiacals and kidney diseases--part I].
    Sakac V; Sakac M
    Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin and tryptophan derivatives as free radical scavengers and antioxidants.
    Reiter RJ; Tan DX; Cabrera J; D'Arpa D
    Adv Exp Med Biol; 1999; 467():379-87. PubMed ID: 10721079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
    Reiter RJ; Tan DX; Gitto E; Sainz RM; Mayo JC; Leon J; Manchester LC; Vijayalaxmi ; Kilic E; Kilic U
    Pol J Pharmacol; 2004; 56(2):159-70. PubMed ID: 15156066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin: detoxification of oxygen and nitrogen-based toxic reactants.
    Reiter RJ; Tan DX; Manchester LC; Lopez-Burillo S; Sainz RM; Mayo JC
    Adv Exp Med Biol; 2003; 527():539-48. PubMed ID: 15206772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of melatonin in the reduction of oxidative stress. A review.
    Reiter RJ; Tan DX; Osuna C; Gitto E
    J Biomed Sci; 2000; 7(6):444-58. PubMed ID: 11060493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo protection by melatonin against delta-aminolevulinic acid-induced oxidative damage and its antioxidant effect on the activity of haem enzymes.
    Princ FG; Maxit AG; Cardalda C; Batlle A; Juknat AA
    J Pineal Res; 1998 Jan; 24(1):1-8. PubMed ID: 9468112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.